Plant-Based Bioactive Molecules as Anticancer Drugs/Formulations
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 343
Special Issue Editors
Interests: nanoemulsions; bioactive natural extracts; controlled drug delivery; nanoencapsulation; food ingredients; functional and nutraceutical foods; bioavailability
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recognizing the loss of millions of cancer patients annually, negating malignant metastatic conditions remains paramount. In meeting this objective, plant-derived bioactive molecules or phytochemicals offer great promise. Phytochemicals are active substances with therapeutic abilities against various cancers. Accumulating evidence has shown that plant-derived bioactive compounds are promising candidates for inhibition of tumor growth and metastasis, which has a significant influence on tumor progression, the microenvironment, and drug resistance in multifarious cancers. The primary objective of this SI is to describe what we know to date about plant-derived active compounds, application strategies as extracts/drugs or nanoformulations, pharmacologic action, molecular or specific target delivery and bioavailability as cancer therapeutics, and recent trends and gaps in phytochemical-based anticancer drug discovery. Plant-based bioactive molecules that need a special chemical formula in order to determine their anticancer efficacy will be considered. In addition, emphasis will also be given to information about anticancer phytochemicals evaluated at the preclinical and clinical levels. In summary, this SI will describe the promising application of phytochemicals or phytochemotherapy and recent technological interventions against cancer that have the potential to enhance therapeutic effectiveness, reduce the associated side effects, and improve clinical outcomes.
Dr. Minaxi Sharma
Dr. Deepti Diwan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- plant-derived anticancer nanoparticles
- nanoencapsulation
- anticancer activities and mechanism of action
- nano-drug formulations
- phyto-chemotherapy
- targeted and controlled delivery
- bioavailability
- novel cancer remedies
- adverse effects associated with plant-derived anticancer compounds
- recent advances and future perspectives for plant-derived anticancer compounds
